Exclusive-Fed’s Bostic sees two rate cuts, soft landing next year

By Howard Schneider WASHINGTON (Reuters) -The U.S. central bank can begin reducing interest rates “sometime in the third quarter” of 2024 if inflation falls as expected, Atlanta Federal Reserve President Raphael Bostic said on Friday, pushing back against expectations of an imminent move but outlining a deliberative process that will gather steam in coming weeks….

Read More

Exclusive-US FDA finds control lapses at Moderna manufacturing plant

By Patrick Wingrove (Reuters) – U.S. drug regulators in September found quality control lapses at Moderna’s main factory including with equipment used to manufacture drug substance for its COVID-19 vaccine, according to the report obtained by Reuters via a Freedom of Information Act request. The Sept. 11-21 inspection by the U.S. Food and Drug Administration…

Read More

White House in ‘intensive’ talks with Israel on timing of next phase of Gaza war

JERUSALEM (Reuters) -Washington is pushing Israel to focus the war in Gaza on precise targeting of Hamas leaders rather than widespread bombing and ground operations, the White House national security adviser said on Friday, amid signs of differences over timing. Israel has so far resisted increasing global pressure to rein in the Gaza offensive, which…

Read More

BP restarts pipeline after gasoline spill in Washington state-source

(Reuters) -BP has restarted its Olympic Pipeline that had leaked roughly 25,000 gallons of gasoline near Mount Vernon in Washington state, a source familiar with the pipeline’s operations said on Thursday. The pipeline was restarted following repairs, integrity testing, and regulatory approval of the restart plan, the source said. The company has been cleaning up…

Read More

AstraZeneca, Sanofi to supply 230,000 more RSV infant shots to US market

By Trevor Hunnicutt and Michael Erman WASHINGTON (Reuters) -The makers of a respiratory syncytial virus (RSV) immunization for infants that has been in tight supply will deliver an additional 230,000 doses in January, the White House said on Thursday, after U.S. government officials met with the companies to discuss meeting winter demand. According to a…

Read More

Tesla recalls nearly all vehicles on US roads over lack of Autopilot safeguards

By David Shepardson WASHINGTON (Reuters) -Tesla is recalling over 2 million vehicles in the U.S. to install new safeguards in its Autopilot advanced driver-assistance system, after a federal safety regulator cited safety concerns. The largest-ever Tesla recall appears to cover nearly all vehicles on U.S. roads to better ensure drivers pay attention when using the…

Read More